Paramahamsa Maturu, PhD
About Paramahamsa Maturu, PhD
Paramahamsa Maturu, PhD, is a Clinical Scientist and Study Director at Bristol Myers Squibb in New Jersey, specializing in oncology and in vivo pharmacology research.
Title at Bristol Myers Squibb
Paramahamsa Maturu, PhD, holds the position of Clinical Scientist and Study Director at Bristol Myers Squibb, located in New Jersey, United States. In this role, he contributes to the company's research and development initiatives, specifically focusing on oncology and in vivo pharmacology.
Experience in Oncology Research
Paramahamsa Maturu has extensive experience in conducting both pre-clinical and clinical research, particularly in the field of oncology. His expertise encompasses various models of cancer, including tumor immunology and oncogenic signaling. His work also delves into related areas of metabolism, epigenetics, and DNA damage, marking him as a versatile researcher in the oncology domain.
Expertise in Immune Oncology
Paramahamsa Maturu possesses hands-on experience in immune oncology, including tumor immunology. His work involves the examination and manipulation of oncogenic signaling pathways, with a keen interest in how these pathways can be targeted for cancer therapies.
Collaborative Drug Discovery and Target Validation
Maturu is known for his ability to build collaborative relationships with cross-functional teams engaged in drug discovery, target validation, and translational biology. His efforts in these areas help bridge the gap between basic research and clinical application, fostering innovative approaches to cancer treatment.
Publications and Conference Presentations
Paramahamsa Maturu has a strong track record of publications in high-impact journals, frequently contributing as a corresponding author. He is also a regular presenter at national and international conferences and symposia, where he shares his research findings and insights with the broader scientific community.